LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2020 ,inter alia, to consider and approve the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended on September 30, 2020 along with any other business, if any.<BR> <BR> Further, in continuation to our disclosure on closure of trading window dated September 30, 2020, the trading window for dealing / trading in the securities of the Company by the designated persons was closed from October 01, 2020 and shall remain closed till 48 hours after the announcement of financials results.
|